Valneva, Serum Institute End Chikungunya Vaccine License
SAINT-HERBLAIN, FRANCE | December 31, 2025 — Valneva and Serum Institute of India announced the discontinuation of their license...
vaccine development
Advertisement
Anixa Biosciences Completes Final Patient Visit in Breast Cancer Vaccine Trial
SAN JOSE, Calif., October 7, 2025 – Anixa Biosciences, Inc. (NASDAQ: ANIX), a clinical-stage biotechnology company dedicated to cancer...
FDA Clears HDT Bio’s First-in-Class Tick-Borne Disease Vaccine
SEATTLE, Sept. 19, 2025 – HDT Bio Corporation has announced that the U.S. Food and Drug Administration (FDA) has...
Glycovax Pharma to Develop Pseudomonas Vaccine After NRC License Approval
MONTREAL, Aug. 18, 2025 — Glycovax Pharma has secured a license from the National Research Council of Canada (NRC)...
Advertisement
